[Clinical factors and response to therapy with disease-modifying drugs for multiple sclerosis: the experience of the Tomsk region].
Valentina M AlifirovaM A TitovaEkaterina M KamenskihIa S ShaglaevaD V PashkovskayaN F MusinaT N NikolaevaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
Clinical features of MS are crucial factors associated with DMD response and should be used to prescribe DMD. This factor assessment can improve efficacy of the personalized MS treatment.